Harbour BioMed
Qing Wang has a strong background in programming and statistical analysis, with over 10 years of experience in the pharmaceutical industry. They began their career in 2008 as a Statistician at inVentiv Clinical Solutions before moving on to PPD in 2009, where they worked as a Statistical Analyst and Franchise Leader. In 2011, Qing joined Roche Pharmaceuticals as a Senior Statistical Programming Analyst before joining PAREXEL in 2015 as an Associate Manager of Programming, FSP. They were later promoted to the role of Manager of Programming, FSP in 2017. In 2019, Qing transitioned to HARBOUR BIOMED, where they initially served as the Associate Director of Programming. They currently hold the position of Director and Head of Programming at the company.
Qing Wang completed a Bachelor of Science degree in Physics at the University of Science and Technology of China from 1995 to 2010. From 2000 to 2005, Qing Wang pursued a Master of Arts degree in Mathematics at The Johns Hopkins University. Additionally, from 2005 to 2008, Qing Wang obtained a Master of Science degree in General Statistics at Texas A&M University.
This person is not in any teams
This person is not in any offices
Harbour BioMed
1 followers
Harbour BioMed is an Immune-Driven Global Bio-therapeutics Company discovering, developing and delivering Innovative Therapeutics for Oncology and Immunology. The company's discovery and development programs are centered around its two patented transgenic mouse platforms for human antibody discovery - the H2L2 and the HCAb.